Kodiak Sciences, Inc. (KOD)
99.29
-0.58
(-0.58%)
USD |
NASDAQ |
Oct 12, 16:00
99.26
-0.03
(-0.03%)
After-Hours: 18:42
Kodiak Sciences Cash from Investing (Quarterly) : -0.352M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.352M |
| March 31, 2026 | -0.942M |
| December 31, 2025 | -0.043M |
| September 30, 2025 | -0.06M |
| June 30, 2025 | -0.133M |
| March 31, 2025 | -0.27M |
| December 31, 2024 | -0.124M |
| September 30, 2024 | -0.205M |
| June 30, 2024 | -0.26M |
| March 31, 2024 | -0.166M |
| December 31, 2023 | -27.80M |
| September 30, 2023 | -0.226M |
| June 30, 2023 | 103.84M |
| March 31, 2023 | 173.41M |
| December 31, 2022 | 67.00M |
| September 30, 2022 | 58.73M |
| June 30, 2022 | -443.95M |
| March 31, 2022 | -18.29M |
| Date | Value |
|---|---|
| December 31, 2021 | -10.86M |
| September 30, 2021 | -31.70M |
| June 30, 2021 | -5.452M |
| March 31, 2021 | 9.218M |
| December 31, 2020 | 58.86M |
| September 30, 2020 | 56.39M |
| June 30, 2020 | 56.78M |
| March 31, 2020 | -67.20M |
| December 31, 2019 | -113.28M |
| September 30, 2019 | -0.523M |
| June 30, 2019 | 0.68M |
| March 31, 2019 | -23.87M |
| December 31, 2018 | -0.525M |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 | 0.00 |
| December 31, 2017 | -0.05M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | -92.70M |
| AbbVie, Inc. | -1.197B |
| Mirum Pharmaceuticals, Inc. | -159.99M |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -46.24M |
| Cash from Financing (Quarterly) | 2.963M |
| Free Cash Flow | -159.90M |
| Free Cash Flow Per Share (Quarterly) | -0.7439 |
| Free Cash Flow to Equity (Quarterly) | -43.35M |
| Free Cash Flow to Firm (Quarterly) | -46.59M |
| Free Cash Flow Yield | -2.78% |